NCT05928442 - Interest of Salivary Signature of Endometriosis in the Heathcare Pathway of Adolescent | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 13, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

November 30, 2024

Conditions

Endometriosis

Interventions

DEVICE

in vitro diagnostic medical device

Collection of 2 saliva samples at inclusion.

BEHAVIORAL

Completion of a self-questionnaire

Completion of a self-questionnaire on symptom and quality-of-life at inclusion.

DEVICE

in vitro diagnostic medical device

Collection of 1 saliva sample at the follow-up visit.

Trial Locations (13)

13005

RECRUITING

AP-HM Hôpital de la Conception, Marseille

13090

RECRUITING

Centre chirurgical L'Avancée, Aix-en-Provence

14033

RECRUITING

CHU Caen, Caen

30029

RECRUITING

CHU Caremeau, Nîmes

33000

RECRUITING

Clinique Tivoli-Ducos, Bordeaux

35000

RECRUITING

CHU Rennes, Rennes

49033

RECRUITING

CHU Angers, Angers

69310

RECRUITING

CHU Lyon Sud, Pierre-Bénite

75020

RECRUITING

Hôpital Tenon, Paris

Unknown

RECRUITING

Hôpital de la Citadelle, Liège

RECRUITING

APHP, Hôpital Cochin Port Royal, Paris

RECRUITING

CHU Rouen, Rouen

RECRUITING

Universitätsklinik für Frauenheilkunde, Inselspital Bern, Bern